Request FREE sample PDF
Pharmacy benefit management market
Antidotes Market Report Overview
The global antidotes market size is USD 8.408 billion in 2023 & the market is projected to touch USD 10.97 billion by 2032, exhibiting a CAGR of 3.0% during the forecast period.
The global COVID-19 pandemic has been unprecedented and staggering, with the antidotes market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden spike in CAGR is attributed to the market's growth and demand returning to pre-pandemic levels once the pandemic is over.
A pharmacological or toxicological treatment used to counteract the poisonous effects of a toxin is known as an antidote. They function by either altering the toxin's chemical composition or interfering with the poison's adhesion to biological sites. Since the start of medicine, antidotes have been utilized.
An antidote is a drug that counteracts the effects of a poison or an overdose of another medication. It aids in the neutralization of a toxin's damaging effects in the body and contains scientific approaches that have been utilized to evaluate the therapeutic usage of the antidote. The employment of it in the treatment of current poisoning cases is one of the most significant advancements. The chemical antidote are the most commonly utilized medications. They precisely engage with and neutralize the toxin. Chemical dosage work by either generating a chemical or changing metabolism. Naloxone hydrochloride is the most often used pharmacological antidote for opioid overdose.
COVID-19 Impact: The COVID-19 Underlying Condition Uplifted the Market Growth
The COVID-19 epidemic had a substantial influence on the patient monitoring device market. Because of the increasing number of COVID-19 cases that require continuous patient monitoring, the demand for patient monitoring equipment has increased significantly during the COVID-19 pandemic. Moreover, during the COVID-19 epidemic, industries expanded their production of crucial or necessary medical ailments. COVID-19 has had and will continue to have a diverging impact on antidotes market share. It also claimed that in fiscal year 2022, there will be a continued acceptance and expansion in patient treatments. As a result, the COVID-19 pandemic had a good impact on the antidotes market growth, and the market is increasing rapidly and is expected to continue to rise during the forecast period.
LATEST TRENDS
"The Increased Awareness and Extensive Research to Attract the Market Share"
The worldwide antidotes market is likely to be driven by greater awareness and study on the identification of toxins in venomous bites by enterprises and governments seeking to better understand the antidote and pharmaceuticals. Antidote demand is being driven by an increase in the occurrence of medical conditions associated to antidotes, such as trichotillomania, toxoplasmosis prophylaxis, smoking cessation and reversion of sedation, reversal of opioid sedation, pneumocystis pneumonia prophylaxis, and opioid overdose.
Antidotes Market Segmentation
- By Type
Based on type the market is classified into injection, oral and others.
The injection is the leading part of the type segment in the market.
- By Application
Based on application the market is classified as hospital, clinic and others"."
The hospital for the leading application in the market.
DRIVING FACTORS
"The Healing Properties of Antidotes and Rising Chronic Diseases to Enhance the Market Growth"
Antidotes are substances or therapies that counteract the effects of toxins, poisons, or medications in the body. They are employed in medical crises to counteract or mitigate the adverse effects of hazardous chemicals. The antidote function by a variety of techniques, such as attaching to the harmful material, neutralizing its effects, or increasing the body's natural detoxification processes. It is crucial to remember that not all poisons have specific antidotes, and in some circumstances, treatment may focus on supportive care to control symptoms and remove the toxin from the body.
"Rising Occurrence of Snake Bites, Drug Overdose and Poisoning to Reinforce the Market Growth"
An antidote is a substance that counteracts the effects of poison or over-dosage by another medicine. It aids in neutralizing the harmful effects of a toxin in the body and has scientific methodologies that have been adopted to examine the therapeutic value of antidote. The market is mostly driven by the prevalence of snake bites and the negative consequences connected with them. According to the WHO, around 4.5-5.4 million people are bitten by snakes each year, 1.8-2.7 million of them suffer clinical illness (envenoming) as a result of the bite, and the mortality toll may range from 81,000 to 138,000. This is the key factor driving the growth of the antidotes market. Furthermore, the growing prevalence of drug overdose stimulates the market demand. The most common drug overdose is paracetamol poisoning, which can induce liver damage and failure.
RESTRAINING FACTORS
"The Mandatory Medical Supervision and Several Restrictions to Hamper the Market Share"
It is critical to note that antidotes should only be used under medical supervision as part of a full treatment plan. In the event of a poisoning or overdose, seek immediate medical care by contacting emergency services or a poison control centre. However, various constraints in the antidote market, such as a lack of anti-venoms due to increased anti-venom costs, which has resulted in treatment dropping substantially or even disappearing in some places, are projected to stymie antidote market growth.
Antidotes Market Regional Insights
"North American Region to Rule Out with Rising Chronic Diseases and Advanced Medical and Healthcare Facilities"
North America is likely to have revenue increase during the forecast period because to the high incidence of anaemia and ongoing research & development programmes. Anti-venom production capacity and awareness of clinical features of envenoming, as well as other factors such as increased healthcare spending and enhanced medical facilities, are driving market expansion in the region. Because of technological breakthroughs the area held the largest market share. The North American market is predicted to rise rapidly due to an increase in the occurrence of medical conditions associated with antidotes, such as nerve agent poisoning, methotrexate rescue, methanol poisoning, mercury poisoning, lead poisoning, and gold poisoning.
KEY INDUSTRY PLAYERS
"Prominent Manufacturers to Contribute Towards Expansion of Market"
The report is an extensive research which presents the historic and futuristic performance of industry with competitive landscape analysis which incorporates prominent key players, and revenue trends of industry. The report provides substantial analysis of company profiling, growth insights, supply-demand chain, production and consumption demand, business expansion strategies adopted by top key players. The information is a collusion of latest technological developments, trends, production lines mergers and acquisitions, market study and other factors.
LIST OF TOP ANTIDOTES COMPANIES
- Baxter (U.S.A)
- Fresenius Kabi (Germany)
- Sandoz (Germany)
- Roche (Switzerland)
- Mylan (U.S.A)
- Pfizer (U.S.A)
- Teva (Israel)
- Glaxosmithkline (U.K)
- Merck (U.S.A).
REPORT COVERAGE
The report anticipates a detailed analysis of the global market size at the regional and national level, the segmentation market growth and market share. The prime objective of the report is to help user understand the market in terms of definition, market potential, influencing trends, and the challenges faced by the market. Analysis of sales, the impact of the market players, recent developments, opportunity analysis, strategic market growth analysis, territorial market expansion, and technological innovations are the subject matter explained in the report.
REPORT COVERAGE | DETAILS |
---|---|
Market Size Value In |
US$ 8.408 Billion in 2023 |
Market Size Value By |
US$ 10.97 Billion by 2032 |
Growth Rate |
CAGR of 3% from 2023 to 2032 |
Forecast Period |
2024-2032 |
Base Year |
2023 |
Historical Data Available |
yes |
Regional Scope |
Global |
Segments Covered | |
By Type
|
|
By Application
|
Frequently Asked Questions
-
What value is the market expected to touch by 2032?
The global antidotes market is expected to reach USD 10.97 billion by 2032.
-
What CAGR is the market expected to exhibit by 2032?
The market is expected to exhibit a CAGR of 3.0% by 2032.
-
Which are the driving factors of the market?
The arising complexity and errors faced by the paperwork and the accessibility to the electronic devices are the driving factors of the market.
-
Which are the top companies operating in the market?
Baxter, Fresenius Kabi, Sandoz, Roche, Mylan, Pfizer, Teva, Glaxosmithkline, Merck and others.